Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of vomiting during pediatric procedural sedation with intranasal fentanyl and nitrous oxide
ACTRN12616001213437Phase 3Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vomiting comparing Ondansetron with Placebo (2 arms). Primary endpoint: Incidence of vomiting during the emergency visit primary observation period. Started Oct 2016; status: completed.
02
Drugs
ondansetron
03
Conditions
Vomiting
Beyond the preview
Go deeper on ACTRN12616001213437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001213437.